FDA · Class I · September 16, 2026

Given Imaging recall: Bravo CF capsule delivery device

Given Imaging Ltd. is recalling Bravo CF capsule delivery device because of a laceration hazard – 127,416. The U.S. Food and Drug Administration published the recall on September 16, 2026; it began on August 6, 2026. Distributed nationwide.

Most serious Class I is the most serious level: a reasonable probability that using or eating the product will cause serious health problems or death.

An FDA laboratory that tests medical devices
Illustration: An FDA laboratory that tests medical devices – not the recalled product. Photo: U.S. Food and Drug Administration, public domain.
ProductBravo CF capsule delivery device
BrandGiven Imaging
CompanyGiven Imaging Ltd.
TypeMedical devices
ClassificationClass I
Recall dateAugust 6, 2026
Published by FDASeptember 16, 2026
Quantity127,416
Recall ID99626
As listed by FDA

Recalled products

  1. Bravo CF capsule delivery device, 5-pack, Product Number FGS-0635, Bravo CF capsule delivery device, 1-pack, Product Number FGS-0636. Used to attach a pH monitoring capsule to the esophagus.
    FDA recall number
    Z-3090-2026
    Codes, lots and dates
    Product Number FGS-0635 UDI-DI (GTIN) 07290101369707 Product Number FGS-0636 UDI-DI (GTIN) 07290101369714 Expiration dates prior to and including October 20, 2027 (lot numbers from 64553F up to and including 68912F)
    Quantity
    127,416
    Classification
    Class I
Exactly as the agency lists them

Identifiers and details

FDA event ID
99626
Initiated
Voluntary: Firm initiated
Status
Ongoing
Firm location
Yokne'Am Ilit, Israel

Why it was recalled

The problem: a laceration hazard.

The reason the FDA lists: “Capsule may fail to attach to the esophagus or detach from the delivery device. Risks include patient aspiration/inhalation, perforation of esophagus, obstruction of the airway, hemorrhage/blood loss/bleeding, laceration of the esophagus, a delay in diagnosis, and foreign bodies remaining in the patient.”

Where it was sold

Nationwide. Distribution as the FDA records it: “Worldwide distribution. US nationwide including Puerto Rico; Argentina, Australia, Austria, Bahrain, Brazil, Bulgaria, Canada, Cayman Islands, Chile, China, Czech Republic, Dominican Republic, France, Germany, Greece, Hong Kong, India, Ireland, Israel, Italy, Kazakhstan, Kenya, Luxembourg, Netherlands, New Zealand, Norway, Panama, Poland, Portugal, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Trinidad And Tobago, United Arab Emirates, and United Kingdom.”

What to do

Compare the recall numbers, lot numbers and expiration dates with what you have. Do not stop a prescribed medicine or device without talking to your pharmacist or doctor – they can arrange a replacement from an unaffected lot.

Official notice: FDA Enforcement Report record (event 99626, openFDA) – the same recall numbers can be searched in the FDA Enforcement Report.

Latest

Other medical device recalls

DateRecallProblemAgency
Oct 7, 2026Draeger recall: VentStar Resus NeoMedical devices · 1,063,643 unitsPotential cracks in the hose, which could lead to leakage or the hose falling off.
Most serious
FDA
Class I
Oct 7, 2026Medline Industries recall: Medline Basic Homecare Beds and Medlite Homecare Beds and Accessories and 1 more productMedical devices · 771,127 totala fire hazard
Most serious
FDA
Class I
Oct 7, 2026Karl Storz Endoscopy recall: HOPKINS Telescope 30¿Medical devices · 6 eyepiecesDue to incorrect inside packaging label for eyepiece.
Serious
FDA
Class II
Oct 7, 2026Noxbox recall: NOxBOXi Nitric Oxide Delivery SystemMedical devices · 1,667 unitsPotential for irregular oxygen readings due to a manufacturing issue affecting certain oxy…
Serious
FDA
Class II
Oct 7, 2026Siemens Healthcare Diagnostics recall: Atellica CH Revised C-Reactive ProteinMedical devices · 42940 units (3938 US, 39002 OUS)The potential for falsely elevated results.
Serious
FDA
Class II
Oct 7, 2026Tandem Diabetes Care recall: T:slim Mobile ApplicationMedical devices · 177A beta (early-release) version of the iOS application, version 2.13 (TestFlight) had a sof…
Serious
FDA
Class II
FAQ

About this recall

Is Given Imaging Bravo CF capsule delivery device recalled?

Yes. Given Imaging Ltd. recalled it on August 6, 2026; FDA published it September 16, 2026 (Class I). Only the lots, dates or models listed on this page are included.

Why was it recalled?

Because of a laceration hazard. The reason given: Capsule may fail to attach to the esophagus or detach from the delivery device. Risks include patient aspiration/inhalation, perforation of esophagus, obstruction of the airway, hemorrhage/blood loss/bleeding, laceration of the esophagus, a delay in diagnosis, and foreign bodies remaining in the pat…

What should I do if I have it?

Compare the recall numbers, lot numbers and expiration dates with what you have. Do not stop a prescribed medicine or device without talking to your pharmacist or doctor – they can arrange a replacement from an unaffected lot.

Where was it sold?

Nationwide.

Recalls

More recalls

Source: recall records published by the U.S. Food and Drug Administration (openFDA Enforcement Reports), the USDA Food Safety and Inspection Service, the Consumer Product Safety Commission and the National Highway Traffic Safety Administration, collected twice a day. Product names, lot codes, dates and model numbers are shown exactly as the agency lists them; the agency's notice is the authority. 77.today is not affiliated with any of these agencies.

Cookies

We measure traffic so we know which stories you care about. You can change your choice at any time.